Paper published in a journal (Scientific congresses and symposiums)
End of treatment anti-HBc IgG and HBcrAg predict severe flares after nucleos(t)ide analogue withdrawal in chronic hepatitis B - interim analysis from the multicenter prospective COIN-B trial
Furquim d'Almeida, A; Vanderlinden, A; Bourgeois, S et al.
2025In Journal of Hepatology, 82 (S1), p. 782
Peer Reviewed verified by ORBi
 

Files


Full Text
Coin-B EASL 2025.pdf
Author postprint (834.57 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Furquim d'Almeida, A
Vanderlinden, A
Bourgeois, S
Mulkay, JP
Sersté, T
Mathieu, S
Deressa, B
Sprengers, D
De Vos, M
Callens, J
Shihao, B
Reynaert, D
Deltenre, P
Janssens, F
Negrin-Dastis, S
Starkel, P
Orlent, H
Van Roey, G
Verhelst, X
Moreno, C
Delwaide, Jean ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Van Steenkiste, C
Verlinden, W
Colle, I
Plissonnier, ML
Testoni, B
Zoulim, F
Matheeussen, V
Van Wolleghem, T
More authors (19 more) Less
Language :
English
Title :
End of treatment anti-HBc IgG and HBcrAg predict severe flares after nucleos(t)ide analogue withdrawal in chronic hepatitis B - interim analysis from the multicenter prospective COIN-B trial
Publication date :
2025
Event name :
EASL
Event place :
Amsterdam, Netherlands
Event date :
7-10 May 2025
Audience :
International
Journal title :
Journal of Hepatology
ISSN :
0168-8278
eISSN :
1600-0641
Publisher :
Elsevier, Netherlands
Volume :
82 (S1)
Pages :
S782
Peer review/Selection committee :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 May 2025

Statistics


Number of views
43 (1 by ULiège)
Number of downloads
22 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi